Single-agent docetaxel (TXT) as first-line treatment in metastatic breast cancer (MBC)

被引：0
|
作者：
Guarneri, D. [1 ]
Ratti, R. [1 ]
Venturino, A. [1 ]
Addamo, G. [1 ]
Coccorullo, Z. [1 ]
Colloca, G. [1 ]
Campora, E. [1 ]
机构：
[1] Hosp Sanremo, San Remo, IM, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11515
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    Gamucci, T.
    D'Ottavio, A. M.
    Magnolfi, E.
    Barduagni, M.
    Vaccaro, A.
    Sperduti, I.
    Moscetti, L.
    Belli, F.
    Meliffi, L.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1040 - 1045
  • [22] MERIBEL study: Single-agent eribulin as first-line therapy for taxane-resistant HER2[-] metastatic breast cancer (MBC) patients (pts)
    Ortega, V.
    Lao, J.
    Garau, I.
    Afonso, N.
    Calvo, L.
    Fernandez, Y.
    Martinez-Garcia, M.
    Blanco, E.
    Zamora, P.
    Garcia, M.
    Illarramendi, J.
    Rodriguez, C.
    Aguirre, E.
    Perez, J.
    Cortes Castan, J.
    Llombart-Cussac, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer
    M. Vassilomanolakis
    G. Koumakis
    S. Drufakou
    G. Aperis
    M. Demiri
    V. Barbounis
    J. Missitzis
    A. Efremidis
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 179 - 183
  • [24] First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer
    Vassilomanolakis, M
    Koumakis, G
    Barbounis, V
    Demiri, M
    Panopoulos, C
    Chrissohoou, M
    Apostolikas, N
    Efremidis, AP
    BREAST, 2005, 14 (02): : 136 - 141
  • [25] Vinorelbine and docetaxel as first-line chemotherapy in metastatic breast cancer
    Vassilomanolakis, M
    Koumakis, G
    Drufakou, S
    Aperis, G
    Demiri, M
    Barbounis, V
    Missitzis, J
    Efremidis, AP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (02) : 179 - 183
  • [26] Trastuzumab combined with doublet or single-agent chemotherapy as a first-line treatment for HER2-positive metastatic breast cancer.
    Yu, Yunfang
    Wang, Ying
    Chen, Kai
    Fu, Tuping
    Yao, Herui
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] First-line treatment of metastatic breast cancer
    Trudeau, ME
    ANTI-CANCER DRUGS, 1996, 7 : 9 - 12
  • [28] Current problems in the first-line treatment of metastatic breast cancer: focus on the role of docetaxel
    Montemurro, Filippo
    CLINICAL MANAGEMENT ISSUES, 2010, 4 (03) : 97 - 107
  • [29] Phase II Multicenter Study of Docetaxel and Bevacizumab (Bev) plus /- Trastuzumab as First-Line Treatment of Patients with Metastatic Breast Cancer (MBC)
    Schwartzberg, L. S.
    Hermann, R.
    Blakely, J.
    Richey, S. S.
    Tauer, K. W.
    Childs, B. H.
    CANCER RESEARCH, 2010, 70
  • [30] Sequential treatment with doxorubicin and docetaxel as first-line chemotherapy in metastatic breast cancer (MBC).: Final results of a Phase II GEICAM study
    Alba, E
    Antón, A
    Ribelles, N
    Pérez-Carrión, R
    López-Vega, J
    Llanos, M
    Pelegri, A
    Florián, J
    Menéndez, M
    Godés, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S66 - S66
12345